(Q48472006)

11 February 2018

title

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. (English)

1 reference

11 February 2018

1 reference

1 reference

3

1 reference

11 February 2018

Roshan Cools

1

Roshan Cools

1 reference

11 February 2018

Roger A. Barker

Roger A Barker

4

0 references

Trevor W. Robbins

Trevor W Robbins

5

0 references

Simon J.G. Lewis

2

Simon J G Lewis

1 reference

PubMed ID

16841074

11 February 2018

language of work or name

English

0 references

publication date

12 July 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

180-189

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301153

exact match

0 references

cites work

The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Catecholamine modulation of prefrontal cortical cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Nucleus accumbens cell firing and rapid dopamine signaling during goal-directed behaviors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: facilitation of processes involved in selecting the best strategy in a stressful situation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

New robust 3-D phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

By carrot or by stick: cognitive reinforcement learning in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Dopamine neurons report an error in the temporal prediction of reward during learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

The mechanisms of action of L-dopa in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Distributed neural representation of expected value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Striatal contributions to working memory: a functional magnetic resonance imaging study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Neurophysiological correlates of age-related changes in human motor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Neural bases of set-shifting deficits in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

The basal ganglia: a vertebrate solution to the selection problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Chemical neuromodulation of frontal-executive functions in humans and other animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Limbic-striatal interactions in reward-related processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Getting formal with dopamine and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Fast robust automated brain extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

The nucleus accumbens in monkeys (Macaca fascicularis). III. Reversal learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Rat nucleus accumbens neurons predominantly respond to the outcome-related properties of conditioned stimuli rather than their behavioral-switching properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

A unified statistical approach for determining significant signals in images of cerebral activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

7 January 2021

Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

7 January 2021

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

7 January 2021

Lesions of Nucleus Accumbens Disrupt Learning about Aversive Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

7 January 2021

Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301153

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301153

1 reference

11 February 2018

PubMed ID

16841074

1 reference

11 February 2018